Efficacy and safety of once-daily insulin degludec/insulin aspart compared with once-daily insulin glargine in participants with Type 2 diabetes: a randomized, treat-to-target study-Reference-Cited by-同舟云学术

Efficacy and safety of once-daily insulin degludec/insulin aspart compared with once-daily insulin glargine in participants with Type 2 diabetes: a randomized, treat-to-target study

Published:2016-07-28 Issue:2 Volume:34 Page:180-188
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Kumar S.¹,Jang H. C.²,Demirağ N. G.³,Skjøth T. V.⁴,Endahl L.⁵,Bode B.⁶

Affiliation:

1. Department of Diabetes; Diabetes Care Centre; Thiruvananthapuram India

2. Department of Internal Medicine; Seoul National University Bundang Hospital; Gyeonggi-do South Korea

3. Department of Endocrinology; Baskent University Hospital, Altunizade; Istanbul Turkey

4. Department of Medical and Science, Liraglutide and Obesity; Novo Nordisk A/S; Søborg Denmark

5. Department of R&D Insight; Novo Nordisk A/S; Bagsvaerd Denmark

6. Atlanta Diabetes Associates; Atlanta GA USA

Funder

Novo Nordisk

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dme.13125/fullpdf

Reference18 articles.

1. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Inzucchi;Diabetes Care,2012

2. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group;UK Prospective Diabetes Study (UKPDS) Group;Lancet,1998

3. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study;Ohkubo;Diabetes Res Clin Pract,1995

4. Three-year efficacy of complex insulin regimens in type 2 diabetes;Holman;N Engl J Med,2009

5. Correlates of insulin injection omission;Peyrot;Diabetes Care,2010

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of iGlarLixi versus IDegAsp in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli‐D randomized controlled trial;Diabetes, Obesity and Metabolism;2024-06-22

2. Clinical perspectives on the frequency of hypoglycemia in treat-to-target randomized controlled trials comparing basal insulin analogs in type 2 diabetes: a narrative review;BMJ Open Diabetes Research & Care;2024-05

3. Scientific advisory on nocturnal hypoglycemia in insulin-treated patients with diabetes: Recommendations from Indian experts;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2022-09

4. Twenty Years of Insulin Gla-100: A Systematic Evaluation of Its Efficacy and Safety in Type 2 Diabetes Mellitus;Diabetes Therapy;2022-06-30

5. Efficacy and Safety of Insulin Degludec/Insulin Aspart (IDegAsp) in Type 2 Diabetes: Systematic Review and Meta-Analysis;Cureus;2022-06-02